title: Has the time come for genomic tests to guide the use of adjuvant chemotherapy in node-positive breast cancer?
authors.affiliation: Breast Cancer Translational Research Laboratory (BCTL), Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium hatem.azim@bordet.be.
authors.forename: H A
authors.initials: HA
authors.lastname: Azim
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology*; D009364:Neoplasm Recurrence, Local; D009570:Nitriles / Q000627:therapeutic use*; D013629:Tamoxifen / Q000627:therapeutic use*; D014230:Triazoles / Q000627:therapeutic use*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D009570:Nitriles; D014230:Triazoles; D013629:Tamoxifen